ICM-203 / LG Chem, Yonsei Technology Holdings 
Welcome,         Profile    Billing    Logout  

3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ICM-203 / Yonsei Technology Holdings
NCT04875754: A Study Evaluating the Safety, Tolerability, and Range of Biologically Active Doses of ICM-203 in Mild to Moderate Knee Osteoarthritis

Recruiting
1/2
16
RoW
ICM-203, Placebo
ICM Biotech Australia Pty Ltd.
Osteoarthritis, Knee
03/25
12/25
NCT05454566: A Study Evaluating the Safety, Tolerability, and Activity of ICM-203 in Subjects With Knee Osteoarthritis.

Not yet recruiting
1/2
18
NA
ICM-203
ICM Co. Ltd.
Osteoarthritis, Knee
05/25
11/26
NCT05752032: A Long Term Follow-up Study of Subjects Who Received ICM-203 or Matching Placebo

Enrolling by invitation
N/A
16
RoW
ICM-203, Placebo
ICM Co. Ltd.
Osteoarthritis, Knee
12/28
12/28

Download Options